Press release
SGD Pharma showcases new post-consumer recycled glass packaging at Luxe Pack Monaco 2024
Paris La Défense, FRANCE - 23rd September 2024: SGD Pharma, a global cosmetic and pharmaceutical glass packaging provider, successfully completed its first campaign using 20 percent post-consumer recycled (PCR) glass cullet. The new sustainable PCR glass bottles, manufactured at SGD Pharma's Zhanjiang, China plant, will debut at Luxe Pack Monaco, the leading trade show dedicated to luxury cosmetic and beauty packaging taking place between 30th September and 2nd October 2024.The PCR glass bottles offer improved sustainability by reducing the use of virgin raw materials and carbon emissions thanks to less energy consumption during the melting process. This provides cosmetics brands with a more sustainable primary packaging option which will contribute to reducing their Scope 3 emissions.
The PCR glass manufacturing is a strategic part of SGD Pharma's company-wide goal to reduce its carbon footprint globally by 35 percent in 2030 and by 65 percent in 2040 (Scope 1&2) compared to 2020 results and to achieve the 1.5°C SBTi trajectory to which SGD Pharma is committed. FEVE - The Federation of European manufacturers of glass containers - states that on average, a 10% increase of cullet in the furnace decreases its energy use by 3% and CO2 emissions by 5%.
During its first campaign, the glass bottles produced by SGD Pharma contained 20% PCR glass cullet according to FEVE's standards. All the PCR cullet used at Zhanjiang plant undergoes extensive testing both before and after entering the furnace to ensure purity and clarity of the glass. The resulting PCR glass bottles maintain the same levels of aesthetic quality, functionality and safety (with the absence of heavy metals and other prohibited materials) as conventional glass bottles, while simultaneously being more environmentally friendly.
Frédéric Barbier, General Manager China and APAC, commented: "Glass can be infinitely recycled, which is a great advantage over plastic as a packaging material. For the past ten years, the cosmetic glass industry in Europe has used PCR glass as standard and has experienced a significant reduction in its carbon footprint as a result. Sourcing compliant PCR glass cullet in China is a challenge which is why we're proud to be the first beauty and pharmaceutical glass maker in China to launch a PCR campaign that complies with international standards. Our first campaign incorporated 20% PCR was a resounding success, and we look forward to a second campaign in coming months with plans to implement regular PCR campaigns in 2025 to answer growing demand for sustainable packaging in the cosmetics and beauty industry."
SGD Pharma's cosmetic glass offerings at Luxe Pack Monaco 2024 edition satisfy the three Rs: Reduce, Reuse and Recycle. NOVA, a lightweighting glass solution, reduces greenhouse gas (GHG) emissions by combining the exceptional functional and aesthetic performance of glass with weight optimization. As such, the new 200ml bottle from the company's NOVA range boasts reduced CO2 emissions by approximately 20 percent compared with the original Dorado bottle. Also on display, ECLIPSE, SGD Pharma's bespoke refillable glass packaging allows customers to reuse glass jars by effortlessly replenishing a new product-filled capsule, reducing single-use packaging and environmental impact. Finally, the new PCR glass bottles will be the first of their kind manufactured in SGD Pharma's China plant to meet the needs of customers for environment conscious packaging in the cosmetics and beauty sectors.
SGD Pharma boasts a wealth of expertise in developing industry-leading packaging solutions and is the market leader in the manufacture of glass packaging for cosmetics and beauty brands in the Asia Pacific region. Visit us at booth RC18 to see the most innovative sustainable cosmetic and beauty glass products and talk to our team of experts about how we can achieve your requirements while delivering on the promise of sustainability.
Liberty Tower 17 place des Reflets CS 30300 92097 Paris La Défense Cedex
Marketing & Communication SGD Pharma:
Rui Ding - rui.ding@sgdgroup.com
Cyril Coffin-Eltrich - cyril.coffin-eltrich@sgdgroup.com
About SGD Pharma
SGD Pharma is a global producer of molded and tubular glass for pharmaceutical primary packaging. Building on over a century of expertise, we provide exceptional quality packaging solutions dedicated to parenteral, oral, and nasal products for every therapeutic application. Our worldwide clients are supported by more than 90 agents and distributors and benefit from ongoing innovation at our five best-in-class ISO 15378 certified, GMP compliant manufacturing plants, giving a truly global supply chain infrastructure.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SGD Pharma showcases new post-consumer recycled glass packaging at Luxe Pack Monaco 2024 here
News-ID: 3677244 • Views: …
More Releases from SGD Pharma
SGD Pharma showcases its SEALIAN platform at Pharmapack Europe 2025
Paris La Défense, FRANCE - 20th January 2025: SGD Pharma, a global market leader in pharmaceutical glass primary packaging solutions, will present its innovative range of products and services, including its platform Sealian, an internal treatment that enhances the performance of molded glass vials, on its booth B55 & B59 at Pharmapack. Held in Paris, France, Pharmapack is the leading European trade show for pharmaceutical packaging taking place between…
SGD Pharma releases its latest sustainability report underscoring its global com …
Paris La Défense, FRANCE - June 12th 2024: SGD Pharma, global leader in glass pharmaceutical packaging, has published its latest 2023 Corporate Social Responsibility (CSR) Report illustrating the sustainable practices deeply embedded in its business ethos. The company-wide commitment towards a safer and healthier environment is guided by its dedication to pharmaceutical glass packaging and reflects its responsibility towards the planet. The newly published 2023 Report celebrates achievements across three…
SGD Pharma defines 2024 growth strategy as it strives for market leadership with …
Paris La Défense, FRANCE - SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.
Underpinning this objective Rousseau outlines the investment achievements already notched up in 2023, to illustrate how SGD Pharma has paved the…
SGD Pharma unveils NOVA lightweight glass bottle packaging innovation, addressin …
Paris La Défense, FRANCE - Worldwide glass primary packaging manufacturer, SGD Pharma, announces the expansion of its cosmetics and beauty offering with the introduction of NOVA - a new lightweight glass bottle. This innovative primary packaging solution combines the exceptional functional and aesthetic performance of glass with a reduced carbon footprint linked to weight optimization.
The growing trend for sustainable product sourcing - evidenced in the 'Unpacking Asia-Pacific Consumers' New Love…
More Releases for PCR
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate?
The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024…
Global Real Time Pcr Qpcr And Digital Pcr Dpcr Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Real Time Pcr Qpcr And Digital Pcr Dpcr market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The Real-Time PCR (qPCR) and Digital PCR (dPCR) market is experiencing substantial growth, driven by increasing demand for precise…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision.
Market Size and Growth
The global Q-PCR and D-PCR devices market is estimated to be worth billions of…
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly…